Log in to your Inderes Free account to see all free content on this page.
BioArctic
212
SEK
+1.05 %
BIOA B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
7 following
+1.05%
+6.27%
+9.45%
+34.52%
-5.69%
-21.31%
+77.85%
+121.99%
+631.03%
BioArctic is a research company. The greatest business focus is found in the research and development of treatments and antibodies for diseases that affect the nervous system. Examples of various diseases mainly include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. The company was founded in 2003 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
18.74B SEK
Turnover
28.23M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
13.2.
2025
Annual report '24
21.5.
2025
Interim report Q1'25
28.8.
2025
Interim report Q2'25
ShowingAll content types
BioArctic: First patient dosed in EXIST Phase 2a study in Parkinson's disease
BioArctic: Leqembi® approved in Mexico
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio